Holen Sie sich die Stockscreener-App
0.67
2.46%
-0.017
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.687
Offen:
$0.6897
24-Stunden-Volumen:
105.02K
Relative Volume:
0.26
Marktkapitalisierung:
$28.53M
Einnahmen:
$3.26M
Nettoeinkommen (Verlust:
$-19.52M
KGV:
-1.675
EPS:
-0.4
Netto-Cashflow:
$-24.10M
1W Leistung:
-12.97%
1M Leistung:
-12.97%
6M Leistung:
-32.17%
1J Leistung:
-50.73%
1-Tages-Spanne:
$0.6683
$0.691
1-Wochen-Bereich:
$0.6683
$0.786
52-Wochen-Spanne:
$0.66
$1.49
Scynexis Inc Stock (SCYX) Company Profile
Firmenname
Scynexis Inc
Sektor
Telefon
201-884-5485
Adresse
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Vergleichen Sie SCYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.6804 | 28.80M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
142.89 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.245 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.46 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-22 | Eingeleitet | Guggenheim | Buy |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-11 | Hochstufung | Needham | Hold → Buy |
| 2018-06-27 | Eingeleitet | Maxim Group | Buy |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-10 | Eingeleitet | ROTH Capital | Buy |
| 2017-05-09 | Herabstufung | Needham | Buy → Hold |
| 2017-03-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-07 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2016-08-17 | Eingeleitet | Guggenheim | Buy |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-08-09 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | Eingeleitet | Brean Capital | Buy |
| 2015-12-29 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-11-16 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-06-10 | Eingeleitet | Needham | Buy |
| 2014-05-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2014-05-29 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
Why SCYNEXIS Inc. (135A) stock stays resilient2025 Retail Activity & Real-Time Volume Triggers - newser.com
Should I hold or sell SCYNEXIS Inc. stock in 2025Gap Up & Real-Time Buy Signal Alerts - newser.com
Live market analysis of SCYNEXIS Inc.Profit Target & Weekly Market Pulse Alerts - newser.com
Is SCYNEXIS Inc. stock bottoming outJuly 2025 Trade Ideas & Stock Portfolio Risk Management - newser.com
Why SCYNEXIS Inc. (135A) stock benefits from AI revolution2025 Key Lessons & Growth Focused Entry Reports - newser.com
How geopolitical tensions affect SCYNEXIS Inc. stock2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Analyzing recovery setups for SCYNEXIS Inc. investors2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Will SCYNEXIS Inc. stock recover faster than peers2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Can SCYNEXIS Inc. stock maintain growth trajectoryJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
How SCYNEXIS Inc. (135A) stock performs in volatility spikesWeekly Market Summary & Long-Term Growth Stock Strategies - newser.com
How to build a dashboard for SCYNEXIS Inc. stockAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
How supply chain issues affect SCYNEXIS Inc. stockForecast Cut & Fast Exit/Entry Strategy Plans - newser.com
Guggenheim Lowers Price Target for SCYNEXIS (SCYX) but Maintains Buy Rating | SCYX Stock News - GuruFocus
Guggenheim lowers SCYNEXIS stock price target to $3 after GSK trial resolution - Investing.com
How interest rate cuts could boost SCYNEXIS Inc. stockTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
SCYNEXIS Inc. stock daily chart insightsJuly 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Why SCYNEXIS Inc. stock is rated strong buyExit Point & Reliable Price Breakout Signals - Fundação Cultural do Pará
Is SCYNEXIS Inc. stock ready for a breakoutPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Does SCYNEXIS Inc. fit your quant trading model2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Finanzdaten der Scynexis Inc-Aktie (SCYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.04%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):